Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
DE:4AB
Stock Latest News
The Fly
AbbVie announces results from Phase 2 IMGN853-0420 trial
7h ago
ABBV
Premium
The Fly
AbbVie price target raised to $249 from $242 at Guggenheim
3d ago
ABBV
Premium
The Fly
Trump Trade: AbbVie sues White House over discount drug program
3d ago
NNE
SPY
Premium
The Fly
AbbVie sues White House over discount drug program, Axios says
4d ago
ABBV
Premium
The Fly
AbbVie price target lowered to $240 from $250 at Cantor Fitzgerald
5d ago
ABBV
Premium
The Fly
AbbVie should be bought on recent selloff, says JPMorgan
6d ago
ABBV
Premium
The Fly
AbbVie, Genentech to sell popular commercial drugs on TrumpRx, CBS says
6d ago
ABBV
CHRO
Premium
The Fly
Oruka Therapeutics price target raised to $125 from $60 at Guggenheim
7d ago
ABBV
ORKA
Premium
Ratings
AbbVie: Resilient Core, Growing Aesthetics, and Strategic Acquisitions Underpin Buy Rating
11d ago
ABBV
Premium
Ratings
AbbVie: Immunology Strength, Strategic Acquisitions, and Patent Headwind Execution Support Buy Rating
13d ago
ABBV
Premium
The Fly
AbbVie call volume above normal and directionally bullish
16d ago
ABBV
Premium
The Fly
AbbVie named Official Pharmaceutical Partner of Major League Baseball
19d ago
ABBV
Premium
Weekend Updates
AbbVie Stock Slides as Insider Selling Spooks Investors
22d ago
ABBV
Premium
The Fly
AbbVie, Alloy Therapeutics enter agreement to develop antibody platform
27d ago
ABBV
Premium
The Fly
AbbVie’s Allergan Aesthetics launches Skin Quality Index
27d ago
ABBV
Premium
Ratings
Neutral Hold on AbbVie as Early Cardiometabolic Pipeline Shows Promise but Trails Leading Competitors
1M ago
ABBV
Premium
The Fly
AbbVie reports ‘positive’ results from Phase 1 study of ABBV-295
1M ago
ABBV
Premium
Company Announcements
AbbVie Completes $8 Billion Senior Notes Financing Offering
1M ago
8K
ABBV
Premium
The Fly
AbbVie’s neuroendocrine carcinoma treatment granted FDA orphan designation
1M ago
ABBV
Premium
The Fly
AbbVie reports ‘positive’ results from Phase 3 AFFIRM study of Skyrizi
1M ago
ABBV
Premium
Company Announcements
AbbVie Announces $7.5 Billion Senior Notes Offering
2M ago
8K
ABBV
Premium
The Fly
Psychedelic: AtaiBeckley reports EMP-01 met primary objective in Phase 2a trial
2M ago
PFE
ABBV
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
